United Kingdom · Question · Written question
UIN 24850
Bladder Cancer: Durvalumab
Introduced
20 January 2025
Last action
27 January 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
27 January 2025
Summary
To ask the Secretary of State for Health and Social Care, what his planned timetable is for the rollout of Durvalumab for the treatment of bladded cancer.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
20 January 2025
Written question
To ask the Secretary of State for Health and Social Care, what his planned timetable is for the rollout of Durvalumab for the treatment of bladded cancer.
Source: Commons
27 January 2025
Answer
The National Institute for Health and Care Excellence (NICE) makes recommendations on whether new medicines should be funded by the National Health Service based on their costs and benefits. Wherever possible, NICE aims to align its processes with the reg...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-01-20/24850
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1756701
- uk · wq-1756701 · source updated 27 January 2025